11:48 AM EDT, 09/16/2024 (MT Newswires) -- (Adds Bausch + Lomb declines to comment in the fourth paragraph.)

Bausch + Lomb ( BLCO ) is exploring a potential sale as it navigates a complex separation from its debt-laden parent company, Bausch Health, Financial Times reported Monday, citing unnamed people familiar with the matter.

The eye care business, valued at over $10 billion including debt, is working with Goldman Sachs to gauge interest from private equity buyers, the report said.

The sale process may lead to a significant premium, but no deal is guaranteed, the report said.

Bausch + Lomb ( BLCO ) declined a request for comment from MT Newswires.

Shares of the company rose 14% in recent trading.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 17.67, Change: +2.12, Percent Change: +13.67